Utama › Kanser Darah
Kajian klinikal Kanser Darah sedang mengambil peserta di AS
153 kajian untuk Kanser Darah sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX46 kajian
- New York City, NY26 kajian
- Boston, MA25 kajian
- Washington, DC19 kajian
- Baltimore, MD18 kajian
- Seattle, WA18 kajian
- Los Angeles, CA17 kajian
- Durham, NC16 kajian
- Chicago, IL15 kajian
- Philadelphia, PA14 kajian
- Atlanta, GA13 kajian
- Nashville, TN13 kajian
- Edison, NJ13 kajian
- Columbus, OH13 kajian
- Baldwin Park, CA13 kajian
- Milwaukee, WI12 kajian
- Detroit, MI12 kajian
- Dallas, TX12 kajian
- Minneapolis, MN11 kajian
- Birmingham, AL11 kajian
- Ann Arbor, MI11 kajian
- Omaha, NE10 kajian
- Cincinnati, OH10 kajian
- St. Louis, MO10 kajian
- Jacksonville, FL10 kajian
- Miami, FL9 kajian
- Denver, CO9 kajian
- Cedar Rapids, IA9 kajian
- Memphis, TN9 kajian
- San Antonio, TX8 kajian
- Salt Lake City, UT8 kajian
- Aurora, CO8 kajian
- Clifton, NJ8 kajian
- San Francisco, CA8 kajian
- Tampa, FL8 kajian
- Buffalo, NY7 kajian
- Madison, WI7 kajian
- Grand Rapids, MI7 kajian
- Charlotte, NC7 kajian
- Phoenix, AZ7 kajian
Mengikut negeri
- Alabama11 kajian
- Arizona12 kajian
- Arkansas5 kajian
- California35 kajian
- Colorado14 kajian
- Connecticut8 kajian
- Delaware3 kajian
- Florida28 kajian
- Georgia16 kajian
- Illinois16 kajian
- Indiana9 kajian
- Iowa9 kajian
- Kansas7 kajian
- Kentucky10 kajian
- Louisiana6 kajian
- Maryland29 kajian
- Massachusetts26 kajian
- Michigan22 kajian
- Minnesota17 kajian
- Missouri11 kajian
- Nebraska10 kajian
- Nevada4 kajian
- New Hampshire3 kajian
- New Jersey21 kajian
- New York29 kajian
- North Carolina24 kajian
- Ohio22 kajian
- Oklahoma8 kajian
- Oregon8 kajian
- Pennsylvania21 kajian
- Rhode Island4 kajian
- South Carolina8 kajian
- South Dakota5 kajian
- Tennessee20 kajian
- Texas49 kajian
- Utah8 kajian
- Virginia11 kajian
- Washington20 kajian
- West Virginia5 kajian
- Wilayah Columbia7 kajian
- Wisconsin15 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 110 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05724121Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06904066Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069Rutgers University Study of the Genetics of Blood Cancers
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 110 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07714044Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Mengambil pesertaKajian pemerhatian
Umur 0 hingga 38 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06131801A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06697184A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07572006A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04634552Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06910969Genomic Profiling in Cancer Patients
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 24 Sep 2026 · NCT01775072Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06398457Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT04728893Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
Umur 18 hingga 71 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345Wearable Activity Tracking to Curb Hospitalizations
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06587100Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Mengambil pesertaFasa awal 1
Umur 12 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT04744116Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 12 hingga 120 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05470491Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
Mengambil pesertaFasa 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07162038Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07648264Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07743476Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 12 hingga 120 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT05327023Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04242095SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT05375643Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
Mengambil pesertaFasa 1
Sehingga umur 75 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06345027Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.